Iran Says Its Homegrown Flu Vaccine to Hit Market in Weeks

Iranian Vice President for Science and Technology Sorena Sattari has unveiled plans to fulfill the domestic demand for flu vaccine with the products of private companies which will be available within the next few weeks.

Iran to Test COVID-19 Vaccine on Human Soon: Ministry

Addressing a Thursday ceremony, held via videoconference to inaugurate several medical and pharmaceutical projects, Sattari said five flu vaccines will be prepared for human trial until end of the incumbent administration.

All of those vaccines are developed by the private companies, the vice president noted.

He also said one of the domestic companies, run by a young CEO in his 20s, will be supplying the homegrown flu vaccine by the month of Aban, which starts on October 22.

Thanks to the domestic production of flu vaccine, Iran will not face any serious problem next year in supplying the vaccine, the vice president added.

In February, an Iranian knowledge-based company gained the technical know-how to synthesize and mass-produce a flu vaccine after 10 years.

Officials say the homegrown flu vaccine is comparable in quality to the foreign ones, will be available at much lower costs, and has been fully produced with Iranian raw materials.

IFP Editorial Staff

The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.